UnitedHealth, medical costs
Digest more
UnitedHealth Group Incorporated is rated Buy following solid Q3 earnings beat & signs of operational recovery. Learn more about UNH stock here.
UnitedHealth Group's third quarter revenues grew 12% to $113.2 billion, but headwinds have created challenges for the company, with CEO Stephen Helmsley saying there was a “key sense of urgency” across the company to return to performance standards.
UnitedHealth Group (NYSE: UNH) beat earnings expectations this morning, posting adjusted EPS of $2.92 against a consensus of $2.82. The stock opened near $379, buoyed by the EPS beat and a raised full-year guidance.
UnitedHealth Optum sours on affiliated physician model and plans to reduce providers by 2026 to align with value-based care policies.
UnitedHealth Group raised its annual profit forecast on Tuesday and said it aims for a return to growth in 2026 that should accelerate in 2027, in a sign that turnaround efforts under new CEO Stephen Hemsley were gaining steam.
For the third quarter, UnitedHealth reported adjusted earnings per share of $2.92 compared with $7.15 a year earlier. Revenue rose to $113.2 billion from $100.8 billion.
UnitedHealth Group Inc. beat Wall Street expectations for third-quarter earnings and raised its outlook for the year, a sign that the health conglomerate has stabilized after a major meltdown.
UnitedHealth Group expects its Medicare Advantage enrollment will shrink by 1 million people next year, as the insurer trims offerings across the country while focusing on higher profit margins as the nation’ s largest provider of the government-backed coverage.
News Nation on MSN
UnitedHealth faces scrutiny over nursing home practices
Democratic Sens. Elizabeth Warren and Ron Wyden demanded the insurance company hand over relevant records by September.
UnitedHealth Group (UNH) remains a solid Buy despite valuation risks. UNH remains the most expensive among peers. See more analysis here.
Feedback